Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
SBDS pseudogene 1 (SBDSP1) is a non-functional copy of the chromosome 7 SBDS gene, sharing approximately 97% nucleotide sequence identity. SBDSP1 itself does not produce protein or have direct cellular functions. Its primary clinical relevance stems from gene conversion events with SBDS, which commonly result in pathogenic mutations leading to Shwachman-Diamond syndrome (SDS). These gene conversions account for most disease-causing SBDS mutations in SDS patients, complicating genetic diagnosis due to the pseudogene’s near-identical sequence. SBDSP1 is not a drug target, receptor, enzyme, or transporter and is not involved in molecular signaling, biological processes, or therapeutic interventions. SBDS (the *functional* gene) is a ribosome maturation factor with critical biological roles and is implicated in Shwachman-Diamond syndrome due to loss-of-function mutations. SBDSP1 (*the pseudogene*) is nearly identical at the sequence level but does not produce a functional protein and is not a therapeutic target.
None. SBDSP1 is not a therapeutic target; however, gene conversion with SBDSP1 leads to mutations in SBDS that cause Shwachman-Diamond syndrome
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on SBDS pseudogene 1 (SBDSP1) (SBDSP1).